Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Require mechanical ventilation <br/ >2. Have oxygen saturation less than or equal to 89 percent <br/ >3. Patients re-infected with SARS-CoV-2 <br/ >4. Suspected or proven serious active bacterial fungal viral or other infection <br/ >5.Patients with positive skin test with IP <br/ >6. Patients with known equine allergies or past medical history of serum sickness <br/ >7. Patient who are HIV, HCV, HbsAg positive or immunocompromised <br/ >8. Patients with significant co-morbidities at screening <br/ >9. Moribund state <br/ >10. Pregnant or nursing women <br/ >11. Participating in other clinical trial

1. Require mechanical ventilation <br/ >2. Have oxygen saturation less than or equal to 89 percent <br/ >3. Patients re-infected with SARS-CoV-2 <br/ >4. Suspected or proven serious active bacterial fungal viral or other infection <br/ >5.Patients with positive skin test with IP <br/ >6. Patients with known equine allergies or past medical history of serum sickness <br/ >7. Patient who are HIV, HCV, HbsAg positive or immunocompromised <br/ >8. Patients with significant co-morbidities at screening <br/ >9. Moribund state <br/ >10. Pregnant or nursing women <br/ >11. Participating in other clinical trial

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

March 26, 2021, 2:21 p.m. oms

1. Require mechanical ventilation <br/ >2. Have oxygen saturation less than or equal to 89 percent <br/ >3. Patients re-infected with SARS-CoV-2 <br/ >4. Suspected or proven serious active bacterial fungal viral or other infection <br/ >5.Patients with positive skin test with IP <br/ >6. Patients with known equine allergies or past medical history of serum sickness <br/ >7. Patient who are HIV, HCV, HbsAg positive or immunocompromised <br/ >8. Patients with significant co-morbidities at screening <br/ >9. Moribund state <br/ >10. Pregnant or nursing women <br/ >11. Participating in other clinical trial

1. Require mechanical ventilation <br/ >2. Have oxygen saturation less than or equal to 89 percent <br/ >3. Patients re-infected with SARS-CoV-2 <br/ >4. Suspected or proven serious active bacterial fungal viral or other infection <br/ >5.Patients with positive skin test with IP <br/ >6. Patients with known equine allergies or past medical history of serum sickness <br/ >7. Patient who are HIV, HCV, HbsAg positive or immunocompromised <br/ >8. Patients with significant co-morbidities at screening <br/ >9. Moribund state <br/ >10. Pregnant or nursing women <br/ >11. Participating in other clinical trial